Systemic inflammation and lung function in young adults

Thorax

Volumn 62, Issue 12, 2007, Pages 1064-1068

  Hancox, Robert J ^a   Poulton, Richie ^a   Greene, Justina M ^b   Filsell, Susan ^a   McLachlan, Christene R ^a   Rasmussen, Finn ^c   Taylor, D Robin ^a   Williams, Michael J A ^a   Williamson, Avis ^a   Sears, Malcolm R ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b MCMASTER UNIVERSITY   (Canada)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; ASTHMA; ATHEROSCLEROSIS; BODY MASS; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SMOKING; SPIROMETRY;

ADULT; BRONCHITIS; C-REACTIVE PROTEIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; VITAL CAPACITY;

EID: 36749059932     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.076877     Document Type: Article

References (39)

1. Friedman GD, Klatsky AL, Siegelaub AB. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976;294:1071-5.
2. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew ana Paisley prospective population study. BMJ. 1996;313: 711-5; discussion 715-6).
3. Schunemann HJ, Dorn J, Grant BJ, et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000;118:656-64.
4. Truelsen T, Prescott E, Lange P, et al. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol 2001;30:145-51.
5. Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2003;158:1171-81.
6. Sin DD, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? : The potential role of systemic inflammation in chronic obstructive pulmonary disease, Circulation 2003;107:1514-9.
7. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
8. Gan WQ, Man SFP, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-80.
9. Wedzicha JA, Seemungal TA, MacCallum PK, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000;84:210-5.
10. de Torres JP, Cordoba-Lanus E, Lopez-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006;27:902-7.
11. Yende S, Waterer GW, Tolley EA, et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 2006;61:10-6.
12. Broekhuizen R, Wouters EF, Creutzberg EC, et al. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006;61:17-22.
13. Hurst JR, Perera WR, Wilkinson TM, et al. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:71-8.
14. Aronson D, Roterman I, Yigla M, et al. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med 2006;174:626-32.
15. Silva PA, Stanton WR. From child to adult: the Dunedin Multidisciplinary Health and Development Study. Auckland: Oxford University Press, 1996.
16. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003;349:1414-22.
17. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978;118(6 Pt 2):1-120.
18. Burney P, Chinn S. Developing a new questionnaire for measuring the prevalence and distribution of asthma. Chest 1987;91(6 Suppl):79S-83S.
19. Society AT. Standardization of spirometry - 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987;136: 1285-98.
20. Sinclair S, Avery S, Brady D, et al. Prediction formulae for normal pulmonary function values in New Zealand European subjects. NZ Med J. 1980;4: 1 May).
21. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
22. Anderson GP. COPD, asthma and C-reactive protein. Eur Respir J 2006;27:874-6.
23. Wouters EF. The systemic face of airway diseases: the role of C-reactive protein. Eur Respir J 2006;27:877-9.
24. Thyagarajan B, Jacobs DR, Apostol GG, et al. Plasma fibrinogen and lung function: the CARDIA Study. Int J Epidemiol 2006;35:1001-8.
25. Williams MJ, Williams SM, Milne BJ, et al. Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults. Int J Obes Relat Metab Disord 2004;28:998-1003.
26. Hancox RJ, Milne BJ, Poulton R, et al. Sex differences in the relation between body mass index and asthma and atopy in a birth cohort. Am J Respir Crit Care Med 2005;171:440-5.
27. 1 decline: a longitudinal population-based study. Respir Med 2006;100:2112-20.
28. Fogarty AW, Jones S, Britton JR, et al. Systemic inflamation and decline in lung function in a general population: a prospective study. Thorax 2007;62:515-20.
29. Tockman MS, Pearson JD, Fleg JL, et al. Rapid decline in FEV1. A new risk factor for coronary heart disease mortality. Am J Respir Crit Care Med 1995;151(2 Pt 1):390-8.
30. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993;91:1351-7.
31. Britton JR, Pavord ID, Richards KA, et al. Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med 1995;151:1383-7.
32. Schunemann HJ, McCann S, Grant BJ, et al. Lung function in relation to intake of carotenoids and other antioxidant vitamins in a population-based study. Am J Epidemiol 2002;155:463-71.
33. Gilliland FD, Berhane KT, Li YF, et al. Children's lung function and antioxidant vitamin, fruit, juice, and vegetable intake. Am J Epidemiol 2003;158:576-84.
34. Brighenti F, Valtuena S, Pellegrini N, et al. Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects. Br J Nutr 2005;93:619-25.
35. Fung TT, Rimm EB, Spiegelman D, et al. Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 2001;73:61-7.
36. Lopez-Garcia E, Schulze MB, Fung TT, et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004;80:1029-35.
37. Vollmer WM, Johnson LR, McCamant LE, et al. Methodologic issues in the analysis of lung function data. J Chronic Dis 1987;40:1013-23.
38. Poulton R, Hancox R, Milne B, et al. The Dunedin Multidisciplinary Health and Development Study: are its findings consistent with the overall New Zealand population? N Z Med J 2006;119:U2002.
39. Lakoski SG, Herrington DM, Siscovick DM, et al. C-reactive protein concentration and incident hypertension in young adults: the CARDIA Study. Arch Intern Med 2006;166:345-9.